10.16
price up icon0.79%   0.08
 
loading
Grifols Sa Adr stock is traded at $10.16, with a volume of 759.89K. It is up +0.79% in the last 24 hours and up +5.18% over the past month. Grifols SA one of is global specialty plasma therapeutics companies developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. Plasma derivatives are proteins found in human plasma, which once isolated and purified, have therapeutic value. These protein-based therapies extend and enhance the lives of individuals who suffer from chronic and acute, often life-threatening, conditions, including primary and secondary immunological deficiencies, Chronic Inflammatory Demyelinating Polyneuropathy, immune-mediated ITP. Products and services are used to diagnose and treat patients with hemophilia, immune deficiencies, infectious diseases and a range of other medical conditions. Majority of revenue is from USA.
See More
Previous Close:
$10.08
Open:
$10.16
24h Volume:
759.89K
Relative Volume:
0.81
Market Cap:
$2.66B
Revenue:
$7.94B
Net Income/Loss:
$225.54M
P/E Ratio:
30.80
EPS:
0.3299
Net Cash Flow:
$709.16M
1W Performance:
-5.22%
1M Performance:
+5.18%
6M Performance:
+36.38%
1Y Performance:
+14.80%
1-Day Range:
Value
$10.07
$10.22
1-Week Range:
Value
$10.05
$10.65
52-Week Range:
Value
$6.19
$11.14

Grifols Sa Adr Stock (GRFS) Company Profile

Name
Name
Grifols Sa Adr
Name
Phone
-
Name
Address
-
Name
Employee
23,800
Name
Twitter
Name
Next Earnings Date
2024-11-07
Name
Latest SEC Filings
Name
GRFS's Discussions on Twitter

Compare GRFS with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Drug Manufacturers - General icon
GRFS
Grifols Sa Adr
10.16 7.20B 7.94B 225.54M 709.16M 0.3299
Drug Manufacturers - General icon
LLY
Lilly Eli Co
711.68 625.77B 53.26B 13.80B -50.20M 15.30
Drug Manufacturers - General icon
JNJ
Johnson Johnson
179.29 424.47B 90.62B 22.66B 18.18B 9.35
Drug Manufacturers - General icon
ABBV
Abbvie Inc
210.60 364.92B 58.33B 3.73B 18.24B 2.10
Drug Manufacturers - General icon
NVS
Novartis Ag Adr
126.98 240.07B 53.40B 13.68B 16.89B 6.9231
Drug Manufacturers - General icon
MRK
Merck Co Inc
87.37 210.36B 63.43B 16.42B 14.72B 6.49

Grifols Sa Adr Stock (GRFS) Upgrades & Downgrades

Date Action Analyst Rating Change
Feb-12-25 Resumed Morgan Stanley Overweight
Mar-12-24 Downgrade Deutsche Bank Hold → Sell
Apr-12-23 Upgrade Morgan Stanley Equal-Weight → Overweight
Mar-03-23 Downgrade Morgan Stanley Overweight → Equal-Weight
Feb-16-23 Upgrade Barclays Underweight → Equal Weight
Jan-18-23 Upgrade Jefferies Hold → Buy
Apr-08-22 Initiated Morgan Stanley Equal-Weight
Nov-05-21 Downgrade Deutsche Bank Buy → Hold
Oct-19-21 Downgrade Barclays Overweight → Underweight
Oct-06-21 Upgrade Citigroup Neutral → Buy
Jun-14-21 Upgrade Deutsche Bank Hold → Buy
Apr-20-21 Initiated Deutsche Bank Hold
Mar-23-21 Upgrade Credit Suisse Neutral → Outperform
Mar-11-21 Upgrade HSBC Securities Hold → Buy
Oct-01-20 Upgrade Citigroup Sell → Neutral
Jun-09-20 Downgrade Citigroup Neutral → Sell
Jun-09-20 Upgrade HSBC Securities Reduce → Hold
Mar-25-20 Downgrade Citigroup Buy → Neutral
Jun-27-19 Upgrade JP Morgan Neutral → Overweight
Feb-08-19 Downgrade Berenberg Buy → Hold
Oct-11-18 Upgrade Berenberg Hold → Buy
Jun-01-18 Initiated Barclays Overweight
Oct-31-17 Initiated Citigroup Buy
Jun-30-17 Downgrade Goldman Buy → Neutral
Apr-06-17 Initiated BofA/Merrill Buy
Jan-03-17 Upgrade JP Morgan Neutral → Overweight
Feb-09-16 Upgrade Berenberg Hold → Buy
Jan-04-16 Downgrade Morgan Stanley Equal-Weight → Underweight
Dec-02-15 Downgrade HSBC Securities Buy → Hold
Nov-20-15 Downgrade Berenberg Buy → Hold
Apr-28-15 Downgrade Berenberg Buy → Hold
View All

Grifols Sa Adr Stock (GRFS) Latest News

pulisher
Aug 07, 2025

Plasma Derived Medicine Market to Reach USD 37.4 Billion by 2034, Growing at 8.05% CAGR - GlobeNewswire Inc.

Aug 07, 2025
pulisher
Jul 29, 2025

CNH Industrial NV (NYSE: CNH) Stock Forecast: Bearish Sentiment Points To -15.21% Downside In 2025 - stocksregister.com

Jul 29, 2025
pulisher
Jun 30, 2025

Oppenheimer Asset Management Inc. Acquires 23,980 Shares of Grifols, S.A. (NASDAQ:GRFS) - Defense World

Jun 30, 2025
pulisher
May 28, 2025

ADMA Biologics Vs. Grifols: Which Plasma Therapy Stock Is The Better Buy? - Barchart.com

May 28, 2025
pulisher
May 22, 2025

Grifols: If This Works Out, It Has Massive Upside (NASDAQ:GRFS) - Seeking Alpha

May 22, 2025
pulisher
May 02, 2025

Grifols S.A. Investigated by Block & Leviton For Potential Securities Law Violations; Investors Who Have Lost Money Are Encouraged to Contact the Firm - ACCESS Newswire

May 02, 2025
pulisher
Apr 28, 2025

SMRT’s latest rating updates from top analysts. - knoxdaily.com

Apr 28, 2025
pulisher
Apr 28, 2025

Investing in Grifols SA ADR (GRFS): What You Must Know - knoxdaily.com

Apr 28, 2025
pulisher
Apr 28, 2025

Investing in Apellis Pharmaceuticals Inc (APLS) Is Getting More Attractive - knoxdaily.com

Apr 28, 2025
pulisher
Apr 28, 2025

A company insider recently sold 10,000 shares of News Corp [NWSA]. Should You also Consider to Sale? - knoxdaily.com

Apr 28, 2025
pulisher
Apr 28, 2025

Raymond James Downgrades Truist Financial Corporation (TFC) to a Mkt perform from an Outperform - knoxdaily.com

Apr 28, 2025
pulisher
Apr 28, 2025

AT&T, Inc (T) rating upgrades by Exane BNP Paribas - knoxdaily.com

Apr 28, 2025
pulisher
Apr 25, 2025

Grifols SA ADR (GRFS) Stock: Uncovering a 52-Week Range and Trading Volume - investchronicle.com

Apr 25, 2025
pulisher
Apr 25, 2025

Lazard Inc (LAZ) Stock: 52-Week Performance Insights and Trading Volume - investchronicle.com

Apr 25, 2025
pulisher
Apr 25, 2025

Can Verra Mobility Corp Bounce Back? 52-Week Performance and Analyst Predictions - investchronicle.com

Apr 25, 2025
pulisher
Apr 25, 2025

RYAN’s Market Whiplash: 0.32% YTD Rise, -10.03% Plunge in 30 Days - investchronicle.com

Apr 25, 2025
pulisher
Apr 25, 2025

A significant driver of top-line growth: Grifols SA ADR (GRFS) - Sete News

Apr 25, 2025
pulisher
Apr 25, 2025

SpringWorks Therapeutics Inc (SWTX) Stock: From Low to High in 52 Weeks - investchronicle.com

Apr 25, 2025
pulisher
Apr 25, 2025

There is no doubt that Coeur Mining Inc (CDE) ticks all the boxes. - Sete News

Apr 25, 2025
pulisher
Apr 23, 2025

GRFS (Grifols SA ADR) may reap gains as insiders became active recently - knoxdaily.com

Apr 23, 2025
pulisher
Apr 23, 2025

BHP’s latest rating updates from top analysts. - knoxdaily.com

Apr 23, 2025
pulisher
Apr 23, 2025

FHN’s latest rating updates from top analysts. - knoxdaily.com

Apr 23, 2025
pulisher
Apr 23, 2025

Lake Street’s latest rating for ORGO stock - knoxdaily.com

Apr 23, 2025
pulisher
Mar 26, 2025

Fox Corporation [FOX] stock was sold by MURDOCH KEITH RUPERT at the price of US$3.08 million - knoxdaily.com

Mar 26, 2025
pulisher
Mar 20, 2025

6 undervalued stocks with low beta - Morningstar

Mar 20, 2025
pulisher
Mar 10, 2025

Deutsche Bank raises Grifols SA price target to EUR11.00 - Investing.com India

Mar 10, 2025
pulisher
Feb 27, 2025

Grifols: Looking At The Longer-Term 2025-2027 Upside After No Sale (GRFS) - Seeking Alpha

Feb 27, 2025
pulisher
Nov 29, 2024

Grifols: More Attractive Than In A Very Long Time (NASDAQ:GRFS) - Seeking Alpha

Nov 29, 2024
pulisher
Nov 28, 2024

Grifols Stock Declines After Brookfield Drops Buyout Offer - Yahoo Finance

Nov 28, 2024
pulisher
Nov 27, 2024

Brookfield Drops $6.8 Billion Offer to Buy Drugmaker Grifols - BNN Bloomberg

Nov 27, 2024
pulisher
Nov 20, 2024

Grifols' Board Rejects Brookfield's Buyout Offer, Stock Down 8% - Yahoo Finance

Nov 20, 2024
pulisher
Nov 19, 2024

Grifols slips as board rebuffs Brookfield’s $6.8B offer (update) - MSN

Nov 19, 2024
pulisher
Nov 19, 2024

Grifols stock slips as Brookfield offer rebuffed (GRFS:NASDAQ) - Seeking Alpha

Nov 19, 2024
pulisher
Oct 03, 2024

Grifols: Here Is Why It's Still A 'Buy' Even If Price Goes Down (NASDAQ:GRFS) - Seeking Alpha

Oct 03, 2024
pulisher
Sep 03, 2024

The UAE Blood Transfusion Diagnostics Market Size & Outlook, 2027 - Grand View Research

Sep 03, 2024
pulisher
Aug 22, 2024

Why Grifols (GRFS) Stock Price Moved Up 7% on Wednesday - Yahoo Finance

Aug 22, 2024
pulisher
Aug 21, 2024

Grifols shares up on potential takeover by Brookfield - Investing.com

Aug 21, 2024
pulisher
Jul 16, 2024

Grifols: Going Private? Brookfield On The Scene (OTCMKTS:GIFLF) - Seeking Alpha

Jul 16, 2024
pulisher
Apr 19, 2024

Grifols 2023 Annual Report on Form 20-F filed with the SEC - PR Newswire

Apr 19, 2024
pulisher
Mar 07, 2024

Grifols S.A. (GRFS – ADR ADR Class B) Shares Decline Again After Gotham City Research Issues Another Critical Report – Hagens Berman - ACCESS Newswire

Mar 07, 2024
pulisher
Feb 17, 2024

AMBAR, an Encouraging Alzheimer's Trial That Raises Questions - Frontiers

Feb 17, 2024
pulisher
Feb 16, 2024

The 10 Most-Bought and Most-Sold European Stocks - Morningstar

Feb 16, 2024
pulisher
Feb 05, 2024

Is First Trust NYSE Arca Biotechnology ETF (FBT) a Strong ETF Right Now? - Yahoo Finance

Feb 05, 2024
pulisher
Jan 26, 2024

ROSEN, TOP RANKED NATIONAL INVESTOR ATTORNEYS, Encourages Grifols, S.A. Investors to Inquire About Securities Class Action InvestigationGRFS, GIKLY, GIFOF, GIFLF - PR Newswire

Jan 26, 2024
pulisher
Jan 25, 2024

ROSEN, LEADING TRIAL ATTORNEYS, Encourages Grifols, S.A. - GlobeNewswire

Jan 25, 2024
pulisher
Jan 18, 2024

ROSEN, A GLOBALLY RESPECTED LAW FIRM, Encourages Grifols, - GlobeNewswire

Jan 18, 2024
pulisher
Jan 11, 2024

Grifols sees China stake sale going ahead despite Gotham City report - Reuters

Jan 11, 2024
pulisher
Jan 09, 2024

BreakingviewsShort attack intensifies Grifols’ health problem - Reuters

Jan 09, 2024
pulisher
Apr 18, 2023

Grifols 2022 Annual Report on Form 20-F filed with the SEC on April 18, 2023 - PR Newswire

Apr 18, 2023
pulisher
Nov 08, 2022

Novo Nordisk A/s Dividend History & Dividend Yield 2024 - INDmoney

Nov 08, 2022
pulisher
Sep 07, 2022

Grifols enters into agreement with Canadian Blood Services to accelerate self-sufficiency in immunoglobulins for Canada - PR Newswire Canada

Sep 07, 2022

Grifols Sa Adr Stock (GRFS) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
drug_manufacturers_general SNY
$51.35
price up icon 1.46%
$114.77
price down icon 1.18%
drug_manufacturers_general PFE
$25.88
price up icon 0.54%
$293.72
price down icon 0.69%
drug_manufacturers_general NVO
$56.98
price up icon 2.76%
drug_manufacturers_general MRK
$87.37
price up icon 1.50%
Cap:     |  Volume (24h):